This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Numab Therapeutics Ag. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Tessa Bieri: Innovator in Antibody Development
Introduction
Tessa Bieri is a prominent inventor based in Morges, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. Her work focuses on creating specific antibodies that target human serum albumin (HSA), which has important implications for various medical applications.
Latest Patents
Tessa Bieri holds a patent for Anti-HSA antibodies. This invention relates to innovative antibodies that are specifically designed to bind to human serum albumin. The development of these antibodies represents a significant advancement in therapeutic options for patients.
Career Highlights
Tessa is currently employed at Numab Therapeutics AG, where she continues to push the boundaries of antibody research. Her expertise and dedication to innovation have positioned her as a key player in her field.
Collaborations
Throughout her career, Tessa has collaborated with talented individuals such as Tea Gunde and Sebastian Meyer. These partnerships have fostered a creative environment that enhances the development of groundbreaking therapies.
Conclusion
Tessa Bieri's work in antibody development exemplifies the impact of innovative research in biotechnology. Her contributions are paving the way for new therapeutic solutions that can improve patient outcomes.